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Abstract
Infection is a common cause of morbidity and mortality in chronic lymphocytic leukemia and should be considered when examining bone marrow specimens to identify
a potentially treatable pathogen.
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A 75-year-old man with a history of chronic lymphocytic
leukemia (CLL) diagnosed in 2015 and currently treated
with ibrutinib presented to the emergency department with
a 1-month history of malaise and generalized fatigue. The
patient denied any recent travel history and had no known
sick contacts. A computed tomography scan showed hepatosplenomegaly and extensive lymphadenopathy. A complete
blood count showed bicytopenia; white blood cell count,
7.8 × 109/L; hemoglobin, 12.3 g/dL; platelets, 39 × 109/L.
Additional laboratory findings included elevated liver enzymes: AST, 81 U/L; ALT, 72 U/L; and elevated alkaline
phosphatase, 353 U/L.
Given the patient's past medical history of CLL, a bone
marrow biopsy was performed and showed hypercellular marrow with multiple lymphohistiocytic aggregates (Figure 1A)
that mimicked CLL. However, the aggregates were predominately composed of T cells rather than B cells, highlighted by CD3 and CD20 staining (Figure 1B,C), favoring
a reactive process. Flow cytometry demonstrated low-level
involvement by CLL, with approximately 3% monoclonal,
kappa-restricted B lymphocytes (Figure 1D). Review of
the bone marrow aspirate showed myeloid precursors with
intracellular morulae (Figure 1E) and ehrlichiosis was confirmed by detection of Ehrlichia species DNA by polymerase
chain reaction. Morulae were not identified in the patient's

peripheral blood smear; however, it has been documented
that morulae can be seen in only 22% to 38% of peripheral
blood smears from ehrlichiosis patients.1,2 Upon further discussion, the patient disclosed that he recently hiked in the
woods of rural Missouri and received numerous tick bites.
The patient was treated with doxycycline 100 mg two times
per day for 10 days and clinically improved.
There have been very few reports of bone marrow findings in patients with ehrlichiosis, but lymphohistiocytic aggregates have been described.2 This unique case highlights
the importance of laboratory testing supported by a thorough
clinical history to ensure accurate diagnosis.
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F I G U R E 1 A, Bone marrow trephine biopsy showing lymphohistiocytic aggregate (hematoxylin and eosin, original magnification ×400).
Immunohistochemistry demonstrating admixed CD3 (B) and CD20 (C) positive lymphocytes in the aggregate. D, Flow cytometric analysis of the
bone marrow aspirate revealed a monoclonal B-cell population comprising ~3% of specimen cellularity (E) Review of the bone marrow aspirate
revealed morulae of Ehrlichia organisms in granulocyte precursors
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